Skip to content
DraconiticResearch
Search Sources API
220,430 studies31 sourcesUpdated 46 min ago

Oncology

5,770 studies495 in 7 days2,675 in 30 days

Filters
Type
Date
Clear

Latest

5,770 studies

  1. Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic dependencies in pancreatic cancer
    Pasquale Laise, Mikko Turunen, Álvaro Curiel‐García +24
    Nature GeneticsPeer-reviewedCC BY-NC-NDFull text24 citedOncologyOpenAlex
  2. Extracellular Vesicles Derived from L-MYC Neural Stem Cells Mediate Neuroprotection in 3D Models of Chemotherapy- and Radiation-Induced Neurotoxicity
    Lance G. A. Nunes, Isabella Vasquez, Brecken Enright +5
    bioRxivPreprintCC BYFull textOncologybioRxivPMC
  3. Electromagnetic navigation bronchoscopy-guided three-dimensional conformal microwave ablation for unresectable peripheral high-risk pulmonary nodules: a mid-term assessment with no real-time intraoperative CT/cone-beam computed tomography guidance
    Yawei Liu, Yan Huang, Xiaodan Lin +7
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  4. Audited vibe coding suggests partial fetal-like convergence of tumor proteomes
    J. G. Meyer
    bioRxivPreprintCC BYFull textOncologybioRxiv
  5. BRIX1 Promotes Hepatocellular Carcinoma Progression via the MAPK/ERK Pathway and Serves as a Prognostic Biomarker
    X. Pan, x. Wang, Y. Zhou
    bioRxivPreprintCC BYFull textOncologybioRxiv
  6. Myelonets define spatiotemporal immunosuppressive programs in ovarian cancer
    I. Niemiec, A. Shabanova, E. Ruuska +10
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  7. Pan-cancer Graph-based Cancer Detection Using the Cell-free DNA Methylome
    L. Zhao, Y. Zeng, D. D. Abelman +2
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  8. Point-of-Care Breath Volatile Organic Compound Analysis as a Tool for Lung Cancer Screening: A Pilot Feasibility Study
    Y. Pichkar, S. Manolakos, K. M. Phillips +2
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  9. DNA Methylation Drives Aberrant Osteochondrogenesis in Keloid and Is Reversible by Decitabine
    H. Li, L. Zhang, C. Liu +7
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  10. Coixenolide Enhances Antitumor Immunity of Cytotoxic CD8+ T Cells by Inhibiting S100A8/A9‐CD36 Axis in Obesity‐Associated Pancreatic Adenocarcinoma
    Kaidi Chen, Rong Chen, Wei Li +18
    Advanced SciencePeer-reviewedCC BY 4.0Full textOncologyPMC
  11. A phase II pilot evaluation of lurbinectedin in patients with advanced gastrointestinal malignancies with DNA repair mutations.
    Alexa F Viniotis, Gayle S Jameson, Betsy C Wertheim +7
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  12. Self-expandable metal stent (SEMS) with iodine-125 intraluminal brachytherapy versus SEMS alone for unresectable malignant distal biliary obstruction: survival and patency analysis.
    Lijie Qiu, Zhenkang Qiu, Xiaobo Fu +5
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  13. B cell depletion improves therapeutic index of combination checkpoint blockade in patients with advanced melanoma
    Kavita M. Dhodapkar, Antonio Matera, Alyssa M. Duffy +6
    The Journal of Clinical InvestigationPeer-reviewedCC BY 4.0Full text2 citedOncologyPMC
  14. Cell-state-dependent responses to PLK1 inhibition reveal a non-canonical microtubule-endolysosomal vulnerability in quiescent leukemia stem cells
    Q. Liu, M. Gojsevic, A. Varesi +18
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  15. Angiosarcoma of the Proximal Phalanx of the Fifth Toe: A Case Report.
    Jooyun Lee, Jihae Lee, Hyun-Jung Kim +4
    Journal of the Korean Society of RadiologyPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  16. Pilomatricoma in an Octogenarian: A Case Report of an Exceptional Late-Life Presentation
    Oliwia Gunia, Maëlys Bresson, Claude Depardieu +3
    The American journal of case reportsPeer-reviewedCC BY-NC-NDOncologyHAL
  17. Concurrent Immune-related Enteritis and Cytomegalovirus Enteritis during Immune Checkpoint Inhibitor Therapy
    Yuka Yamada, Norio Kodaka, Saeko Shinozawa +2
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedOncologyJ-STAGE
  18. Surprisal-based large language models reveal immunologic insights in lobular breast cancer
    B. P. Majumder, J. A. Linak, R. Adamson +8
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  19. Clinicopathological comparison of gastric cancer in young (<45 years) versus elderly (>60 years) patients: a single-center retrospective study.
    Junxuan Zhang, Rui Zhao, Qingshan Bai +2
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  20. Reprogramming cancer at the tipping point
    Christos Adamopoulos, Kostas A. Papavassiliou, Athanasios G. Papavassiliou
    Journal of the National Cancer CenterPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  21. Angiosarcoma in the Setting of Vascular Procedures: A Systematic Review and Our Experiences
    Phil Yi Jun Lu, Joel Ding, Casey Hiu Ching Fung +4
    Interdisciplinary Cardiovascular and Thoracic SurgeryPeer-reviewedCC BY 4.0Full textOncologyPMC
  22. Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial
    J. E. Garber, D. Cameron, C. Campbell +64
    Annals of oncology : official journal of the European Society for Medical OncologyPeer-reviewedCC BYFull text1 citedOncologyPMC
  23. A Drug‐Gated, Modular STAb‐T Immunotherapy With External Control
    Susana Luengo‐Arias, Carmen Domínguez‐Alonso, Ivana Zagorac +21
    Advanced SciencePeer-reviewedCC BY 4.0Full textOncologyPMC
  24. EMB-01, an Anti-EGFR/c-MET Bispecific Antibody, in Patients with Heavily Pretreated Metastatic Colorectal Cancer from a Phase Ib/II, Open-Label, Multicenter Study
    Ting Xu, Christine M. Parseghian, Yanqiao Zhang +15
    Clinical Cancer ResearchPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  25. Boosting ovarian cancer immunotherapy via discoidin domain receptor 2 blockade and CD28 x mucin 1 bispecific antibodies.
    Martina Kunkl, Silvia Malatesta, Flavia Ottavi +18
    BMC medicinePeer-reviewedCC BYFull textOncologyEurope PMCPMC